This trial is conducted in Europe. The aim of the trial is to evaluate the change in disease activity following intravenous (i.v.) administration of two doses of NNC0114-0006 compared to placebo in su...

Condition : Osteoarthritis of the Knee Interventions : Drug: Verapamil; Drug: Placebo Sponsors : Calosyn Pharma, Inc.; Health Decisions Terminated - verified February 2014

This multi-center observational study will evaluate the use of RoActemra/Actemra (tocilizumab) in monotherapy in patients with rheumatoid arthritis. Eligible patients initiated on RoActemra/Actemra tr...

This multi-center observational study will evaluate the use of RoActemra/Actemra (tocilizumab) in monotherapy in patients with rheumatoid arthritis. Eligible patients initiated on RoActemra/Actemra tr...

This multi-center observational study will evaluate the use of RoActemra/Actemra (tocilizumab) in monotherapy in patients with rheumatoid arthritis. Eligible patients initiated on RoActemra/Actemra tr...

Condition : Rheumatoid Arthritis Intervention : Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Biological: Secukinumab (AIN457) Sponsors : Novartis; Novartis Pharmaceuticals Recruiting - verified February 2014

Condition : Knee Osteoarthritis Interventions : Drug: 70 mg lidocaine/ 70 mg tetracaine topical patch; Drug: placebo Sponsors : Northwestern University; Thomas J. Schnitzer; Nuvo Research Inc. Recruit...